Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-002827-87Phase 4Active
Phase 4, randomised trial of ferric carboxymaltose in colorectal cancer (CRC) and anaemia (2 arms), sponsored by Academic Medical Center. Primary endpoint: Hemoglobin normalization rate. Started Oct 2014; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-002827-87.